Search Results for: THERAPEUTIC FOCUS A New Patented
Articles
EXECUTIVE INTERVIEW - Nuritas Pharma: Life Changing Peptide Drug Discoveries for a Changing World August 31, 2020
Nora Khaldi, PhD, Founder and Chief Executive Officer of Nuritas, discusses the company’s innovative approach to accelerating the discovery of novel therapeutic peptides that address unmet patient needs in multiple disease areas.
Eyenovia & Arctic Vision Announce Exclusive Collaboration & License Agreement August 12, 2020
Eyenovia, Inc. and Arctic Vision recently announced they have entered into an exclusive license agreement for Arctic Vision to develop...Oncology Venture Signs Agreement to Out-License Two Pipeline Assets June 29, 2020
Oncology Venture A/S (OV) recently announced it has signed a definitive agreement out-licensing two clinical pipeline assets, LiPlaCis and 2X-111,...Pfenex Announces US Commercial Launch of Teriparatide Injection June 17, 2020
Pfenex Inc. recently announced that its commercialization partner, Alvogen, has launched Teriparatide Injection in the US. Teriparatide Injection (also referred...PFS MANUFACTURING - Prefilled Syringes & Biologics: The Perfect Partnership of Medicine & Delivery June 4, 2020
Anish Parikh charts the twin rise of biologics and PFS, outlines some of the common challenges associated with filling and dispensing, and discusses how a patient-centric partnership approach can help biopharmaceutical companies shorten the development pathway and ensure a reliable supply of safe, effective medicines for the people who need them.
Histogen Announces Investigational Device Exemption Application April 23, 2020
Histogen Inc. recently announced it has submitted an Investigational Device Exemption (IDE) application with the US FDA for the initiation of a….
EXECUTIVE INTERVIEW - Tedor Pharma, Inc.: A Strategy Shift to Serve Both Generic & Branded Companies March 31, 2020
Doug Drysdale, President & CEO of Tedor Pharma, Inc., discusses the FLEXITAB technology, his strategy for managing a shift in business model, and how Tedor is addressing the needs of small- and medium-size companies developing innovative and repurposed small molecules for unmet medical needs.
Conatus Pharmaceuticals & Histogen Enter Definitive Merger Agreement January 30, 2020
Conatus Pharmaceuticals Inc. and Histogen Inc. recently announced the companies have entered into a definitive agreement under which Histogen will merge with a wholly owned subsidiary of….
GeoVax & BravoVax to Collaborate on Development of Coronavirus Vaccine January 27, 2020
GeoVax Labs, Inc. and BravoVax recently announced the signing of a Letter of Intent to jointly develop a vaccine against...OncoCyte Announces Agreement to Acquire Molecular Diagnostics Company January 15, 2020
OncoCyte Corporation recently announced it has entered into an agreement to acquire, through a subsidiary, all of the outstanding capital...Vivera Pharmaceuticals Enters Agreement Clinical Study Agreement With Parexel Biotech December 4, 2019
Vivera Pharmaceuticals, Inc. recently announced it has signed an agreement for Clinical Development Services with Parexel International, a leading provider...Pfenex Receives US FDA Approval for PF708 to Treat Osteoporosis October 10, 2019
Pfenex Inc. recently announced the US FDA has approved the new drug application (NDA) for PF708 submitted under the 505(b)(2) regulatory pathway, with…
Bellerophon Receives Orphan Drug Designation September 18, 2019
Bellerophon Therapeutics, Inc. recently announced the US FDA has granted Orphan Drug Designation to nitric oxide for the treatment of...SPECIAL FEATURE - Injection Devices: Wearables, Connectivity & Patient-Centric Designs Empower Self-Administration September 3, 2019
Contributor Cindy H. Dubin highlights the innovation in injection devices – from wearables to connectivity to varied dose administration – that have occurred in the past year.
Mino-Wrap to be Developed Through an IND Process July 31, 2019
Citius Pharmaceuticals, Inc. recently reported the company's decision to develop Mino-Wrap as a drug through the Investigational New Drug (IND)...Pfenex & Arcellx Announce Development, Evaluation & License Agreement July 29, 2019
Pfenex Inc. and Arcellx, Inc. recently announced a Development, Evaluation, and License agreement under which Arcellx gains access to the proprietary Pfenex Expression Technology platform to advance……
Calixar Signs Exclusive Licensing Agreement With Regeneron May 2, 2019
Calixar SAS (Calixar), a biotechnology company specialized in native membrane protein stabilization, recently announced it has entered into an exclusive...SPECIAL FEATURE - Prefilled Syringes & Parenteral Manufacturing: Flexibility for Faster Development April 30, 2019
Contributor Cindy H. Dubin interviews several contract manufacturers and device developers who are responsible for creating next-generation parenteral drug delivery.
argenx & Halozyme Enter Global Collaboration & License Agreement February 7, 2019
argenx and Halozyme Therapeutics, Inc. recently announced a global collaboration and license agreement that enables use by argenx of Halozyme’s...Melt Pharmaceuticals Initiates Clinical Development Program October 26, 2018
Melt Pharmaceuticals recently announced that following the presentation of clinical data on the MKO Melt (midazolam/ketamine/ondansetron) from a 611-patient IRB...
